Paper36402002
Oral tolerance to prevent anti-drug antibody formation in protein replacement therapies.
Rana J and 2 others. Cell Immunol, 2022. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Oral tolerance to prevent anti-drug antibody formation in protein replacement therapies. Papers, record 36402002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36402002
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Review, Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemophilia A | Major topic |
| Humans | |
| Antibody Formation | |
| Quality of Life | |
| Enzyme Replacement Therapy | |
| Antibodies |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 HL133191 | NHLBI NIH HHS | United States | R01HL133191 | PubMed and NIH |
Source NIH RePORTER
References161
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30,988,509 | Compartmentalized gut lymph node drainage dictates adaptive immune responses. | Nature | 2019 | https://conductscience.org/library/papers/30988509 | PubMed |
| 2 | 21,333,554 | Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. | Immunity | 2011 | https://conductscience.org/library/papers/21333554 | PubMed |
| 3 | 31,985,872 | Combined anti-CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors. | J Thromb Haemost | 2020 | https://conductscience.org/library/papers/31985872 | PubMed |
| 4 | 22,819,863 | An oral CD3-specific antibody suppresses T-cell-induced colitis and alters cytokine responses to T-cell activation in mice. | Gastroenterology | 2012 | https://conductscience.org/library/papers/22819863 | PubMed |
| 5 | 26,286,728 | Giant Heart of Classical Infantile-Onset Pompe Disease With Mirror Image Dextrocardia. | Circ Cardiovasc Imaging | 2015 | https://conductscience.org/library/papers/26286728 | PubMed |
| 6 | 21,447,056 | Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression. | Plant Biotechnol J | 2011 | https://conductscience.org/library/papers/21447056 | PubMed |
| 7 | 17,476,344 | Indoleamine 2,3-dioxygenase and tumor-induced tolerance. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17476344 | PubMed |
| 8 | 1,836,479 | Clonal anergy blocks the response to IL-4, as well as the production of IL-2, in dual-producing T helper cell clones. | J Immunol | 1991 | https://conductscience.org/library/papers/1836479 | PubMed |
| 9 | 23,670,281 | On the road to tolerance--generation and migration of gut regulatory T cells. | Eur J Immunol | 2013 | https://conductscience.org/library/papers/23670281 | PubMed |
| 10 | 17,502,665 | Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. | J Exp Med | 2007 | https://conductscience.org/library/papers/17502665 | PubMed |
| 11 | 15,937,545 | Oral tolerance in the absence of naturally occurring Tregs. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15937545 | PubMed |
| 12 | 15,962,005 | Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. | Cell Death Differ | 2006 | https://conductscience.org/library/papers/15962005 | PubMed |
| 13 | 28,153,098 | Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce. | Mol Ther | 2017 | https://conductscience.org/library/papers/28153098 | PubMed |
| 14 | 3,296,685 | Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. | Adv Immunol | 1987 | https://conductscience.org/library/papers/3296685 | PubMed |
| 15 | 22,318,520 | Extrathymically generated regulatory T cells control mucosal TH2 inflammation. | Nature | 2012 | https://conductscience.org/library/papers/22318520 | PubMed |
| 16 | 21,377,034 | A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. | J Allergy Clin Immunol | 2011 | https://conductscience.org/library/papers/21377034 | PubMed |
| 17 | 9,114,038 | A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9114038 | PubMed |
| 18 | 17,964,218 | Immunogenicity of protein therapeutics. | Trends Immunol | 2007 | https://conductscience.org/library/papers/17964218 | PubMed |
| 19 | 19,129,538 | Elimination of antibodies to recombinant enzyme in Pompe's disease. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19129538 | PubMed |
| 20 | 21,415,489 | Cholera toxin - a foe & a friend. | Indian J Med Res | 2011 | https://conductscience.org/library/papers/21415489 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,752,847 | Plant-Based Systems for Producing Therapeutic Proteins: Current Status and Future Prospects. | BioDrugs | 2026 | https://conductscience.org/library/papers/42752847 | PubMed |
| 40,310,476 | Progress and Challenges in the Treatment of Fabry Disease. | BioDrugs | 2025 | https://conductscience.org/library/papers/40310476 | PubMed |
| 40,002,712 | Anti-Drug Antibody Response to Therapeutic Antibodies and Potential Mitigation Strategies. | Biomedicines | 2025 | https://conductscience.org/library/papers/40002712 | PubMed |
| 39,201,385 | Long-Term Oral Administration of Hyperimmune Egg-Based IgY-Rich Formulations Induces Mucosal Immune Response and Systemic Increases of Cytokines Involved in Th2- and Th17-Type Immune Responses in C57BL/6 Mice. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201385 | PubMed |
| 37,954,612 | Distinct functions and transcriptional signatures in orally induced regulatory T cell populations. | Front Immunol | 2023 | https://conductscience.org/library/papers/37954612 | PubMed |
| 37,423,874 | Potential role for oral tolerance in gene therapy. | Cell Immunol | 2023 | https://conductscience.org/library/papers/37423874 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36402002
GET https://conductscience.org/api/papers/v1/36402002/references?page=2